Agilent Technologies Inc
Change company Symbol lookup
Select an option...
A Agilent Technologies Inc
CCO Clear Channel Outdoor Holdings Inc
COSAF Cosa Resources Corp
HD Home Depot Inc
SRCE 1st Source Corp
PNC PNC Financial Services Group Inc
AAPL Apple Inc
MSFT Microsoft Corp
FAZE FaZe Holdings Inc
SSP E W Scripps Co
Go

Health Care : Life Sciences Tools & Services | Mid Cap Blend
Company profile

Agilent Technologies, Inc. is engaged in providing application-focused solutions that include instruments, software, services, and consumables for the entire laboratory workflow. The Company's life sciences and applied markets segment provides application-focused solutions, which include instruments, consumables and software that enable customers to identify, quantify and analyze the physical and biological properties of substances and products. Its diagnostics and genomics segment includes the genomics, nucleic acid contract manufacturing and research and development, pathology, companion diagnostics, reagent partnership and biomolecular analysis businesses. The Company's Agilent CrossLab segment offers services portfolio, which consists of repairs, parts, maintenance, installations, training, compliance support, software as a service, asset management, consulting, and various other custom services to support the customers' laboratory operations.

Price
Delayed
$110.52
Day's Change
-1.08 (-0.96%)
Bid
--
Ask
--
B/A Size
--
Day's High
111.80
Day's Low
109.77
Volume
(Light)

Today's volume of 717,885 shares is on pace to be much lighter than A's 10-day average volume of 1,689,098 shares.

717,885

Company Profile

Agilent Technologies, Inc. is engaged in providing application-focused solutions that include instruments, software, services, and consumables for the entire laboratory workflow. The Company's life sciences and applied markets segment provides application-focused solutions, which include instruments, consumables and software that enable customers to identify, quantify and analyze the physical and biological properties of substances and products. Its diagnostics and genomics segment includes the genomics, nucleic acid contract manufacturing and research and development, pathology, companion diagnostics, reagent partnership and biomolecular analysis businesses. The Company's Agilent CrossLab segment offers services portfolio, which consists of repairs, parts, maintenance, installations, training, compliance support, software as a service, asset management, consulting, and various other custom services to support the customers' laboratory operations.

Valuation Ratios

Price/Earnings (TTM)
29.34x
Price/Sales (TTM)
4.69x
Price/Book (MRQ)
5.90x
Price/Cash Flow (TTM)
23.16x
TTM = Trailing Twelve Months
MRQ = Most Recent Quarter

Price Performance

Historic Growth and Share Detail

Historic Growth

Annual growth, past 5 years
EPS
Revenue
Dividend

Short Interest

September 2023
Current Month
4.6M
Previous Month
4.0M
Percent of Float
1.56%
Days to Cover
2.0514 Days

Share Information

A is in a share class of common stock
Float
291.7M
Shares Outstanding
292.6M
Institutions Holding Shares
1,390
89.31%

Financial Statements

Balance sheet

Values displayed are in millions.

Income statement

Values displayed are in millions.

Cash flow

Values displayed are in millions.

Company Officers

  • Boon Hwee Koh
  • Michael R. McmullenPres.
  • Robert W. McmahonCFO
  • Philip BinnsCorp.Exec.
  • Michael TangSr.VP

Address

Insider Trading

During the most recent quarter, 4K shares were sold in insider trading.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Insider trading information report provided by Copyright © 2023. All rights reserved.

Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.

Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.